XVIVO is a pioneering medical technology company that has been transforming the field of organ transplantation since its establishment in 1998. As the global leader in life-extending technologies for organs, XVIVO is dedicated to extending the life of all major organs, enabling transplant teams worldwide to save more lives. With a deep commitment to scientific advancements, XVIVO provides clinically optimized solutions for organ, tissue, and cell preservation and perfusion during transplantation through its Thoracic and Abdominal divisions.

These cutting-edge technologies push the boundaries of transplantation medicine, allowing leading clinicians and researchers to revolutionize the field. In addition to its groundbreaking solutions, XVIVO also offers the Organ Procurement Service, a skilled surgical team responsible for the recovery and transportation of donor organs to transplantation clinics. Listed on Nasdaq Stockholm, XVIVO continues to make significant contributions to the medical industry by improving organ transplantation outcomes.

With headquarters in Gothenburg, Sweden, and offices and research sites on multiple continents, XVIVO's global presence ensures widespread access to their life-saving technologies